Table 3.
Demographic characteristics and parallel IgG EIA results of SOT and immunocompetent patient cohorts.
| SOT recipients (n = 599) | Immunocompetent (n = 599) | |
|---|---|---|
| Median age (interquartile range) | 57 (48–63) | 57 (47–63) |
| Sex (male:female) | 364:235 | 360:239 |
| Parallel IgG EIA results (n, %) | ||
| Both EIAs negative | 545 (91.0) | 542 (90.5) |
| HEV-A4 p239 EIA alone positive | 47 (7.8) | 53 (8.8) |
| HEV-C1 p241 EIA alone positive | 2 (0.3) | 0 (0.0) |
| Both EIAs positive; A/C ratio consistent with HEV-C1 exposure | 5 (0.8) | 4 (0.7) |
EIA, enzymatic immunoassay; HEV-A, Paslahepevirus balayani; HEV-C1, Rocahepevirus ratti; SOT, solid organ transplant.